Fugeng Sheng

2.6k total citations
52 papers, 2.2k citations indexed

About

Fugeng Sheng is a scholar working on Biomedical Engineering, Biomaterials and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Fugeng Sheng has authored 52 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Biomedical Engineering, 13 papers in Biomaterials and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Fugeng Sheng's work include Nanoplatforms for cancer theranostics (16 papers), Nanoparticle-Based Drug Delivery (13 papers) and Moyamoya disease diagnosis and treatment (11 papers). Fugeng Sheng is often cited by papers focused on Nanoplatforms for cancer theranostics (16 papers), Nanoparticle-Based Drug Delivery (13 papers) and Moyamoya disease diagnosis and treatment (11 papers). Fugeng Sheng collaborates with scholars based in China, Japan and United States. Fugeng Sheng's co-authors include Yanglong Hou, Jian Lin, Jing Yu, Zhiyi Wang, Yanmin Ju, Zeeshan Ali, Hui Yin, Jun Zhou, Wu Zhong and Yingyu Chen and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Nature Communications.

In The Last Decade

Fugeng Sheng

49 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fugeng Sheng China 21 1.2k 723 548 512 274 52 2.2k
Feng Ren China 27 1.1k 0.9× 999 1.4× 263 0.5× 417 0.8× 194 0.7× 80 2.2k
Rongrong Jin China 27 943 0.8× 516 0.7× 546 1.0× 697 1.4× 112 0.4× 85 2.3k
Xiaoyang Liu China 29 1.4k 1.2× 725 1.0× 670 1.2× 952 1.9× 92 0.3× 115 2.6k
Jinlan Jiang China 30 973 0.8× 721 1.0× 551 1.0× 1.0k 2.0× 101 0.4× 98 2.8k
Andrew Hsu United States 18 592 0.5× 325 0.4× 533 1.0× 583 1.1× 264 1.0× 61 2.2k
Yelin Wu China 31 1.3k 1.1× 855 1.2× 461 0.8× 717 1.4× 118 0.4× 84 2.9k
Xianbing Zhu China 14 1.1k 0.9× 969 1.3× 406 0.7× 729 1.4× 108 0.4× 21 2.2k
Yang Du China 23 1.0k 0.9× 646 0.9× 552 1.0× 1.1k 2.1× 72 0.3× 55 2.5k

Countries citing papers authored by Fugeng Sheng

Since Specialization
Citations

This map shows the geographic impact of Fugeng Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fugeng Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fugeng Sheng more than expected).

Fields of papers citing papers by Fugeng Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fugeng Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fugeng Sheng. The network helps show where Fugeng Sheng may publish in the future.

Co-authorship network of co-authors of Fugeng Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Fugeng Sheng. A scholar is included among the top collaborators of Fugeng Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fugeng Sheng. Fugeng Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Mingming, Zi‐Ai Zhao, Shu Wang, et al.. (2025). Global Hotspots and Research Frontiers of Moyamoya Disease and Radiological Features: A Bibliometric Analysis. World Neurosurgery. 197. 123817–123817.
2.
Lu, Mingming, Hongtao Zhang, Shitong Liu, et al.. (2025). Effects of antiplatelet therapy on reducing stroke risk in patients with moyamoya disease: the role of postcontrast MR vessel wall imaging. European Radiology. 35(10). 5911–5921.
3.
Lu, Mingming, Dongqing Liu, Xu Liu, et al.. (2023). Predictors of Stroke Outcomes in Conservatively Treated Patients With Moyamoya Disease: A Follow‐up MRI Study. Journal of Magnetic Resonance Imaging. 59(4). 1456–1463. 3 indexed citations
4.
Liu, Dongqing, et al.. (2023). Differential Diagnosis of Benign and Malignant Breast Papillary Neoplasms on MRI With Non-mass Enhancement. Academic Radiology. 30. S127–S132. 6 indexed citations
5.
6.
Wang, Zhiyi, Ziyuan Li, Xiaoguang Zhang, et al.. (2022). Amelioration of systemic antitumor immune responses in cocktail therapy by immunomodulatory nanozymes. Science Advances. 8(21). eabn3883–eabn3883. 48 indexed citations
7.
Lu, Mingming, et al.. (2022). The Value of Preoperative Phase-Contrast MRI in Predicting the Clinical Outcome of Moyamoya Disease after Encephalo-Duro-Arterial Synangiosis Surgery. American Journal of Neuroradiology. 43(11). 1582–1588. 1 indexed citations
8.
Zhang, Hongtao, Juan Zhou, Guang Li, et al.. (2022). Deep learning-based automatic segmentation for size and volumetric measurement of breast cancer on magnetic resonance imaging. Frontiers in Oncology. 12. 984626–984626. 35 indexed citations
9.
Liu, Qianqian, Yu Zhang, Huinan Wang, et al.. (2022). Construction of magnetic drug delivery system and its potential application in tumor theranostics. Biomedicine & Pharmacotherapy. 154. 113545–113545. 15 indexed citations
10.
Lu, Mingming, Hongtao Zhang, Dongqing Liu, et al.. (2022). Vessel wall enhancement as a predictor of arterial stenosis progression and poor outcomes in moyamoya disease. European Radiology. 33(4). 2489–2499. 13 indexed citations
11.
Dong, Jinghui, Mingming Lu, Fugeng Sheng, et al.. (2021). Severe Thrombocytopenia and Disseminated Intravascular Coagulation in a Cirrhosis Patient After Intravenous Injection of Gadoxetic Acid. Journal of Magnetic Resonance Imaging. 55(6). 1904–1906. 1 indexed citations
12.
Wang, Zihao, Xinbo Zhou, Shiyong Fan, et al.. (2020). Development of a Novel Dual-Order Protein-Based Nanodelivery Carrier That Rapidly Targets Low-Grade Gliomas with Microscopic Metastasis in Vivo. ACS Omega. 5(32). 20653–20663. 11 indexed citations
13.
Zhou, Juan, et al.. (2019). Evaluation of mammography calcification detection system based on deep learning. Zhonghua fangshexian yixue zazhi. 53(11). 968–973. 1 indexed citations
14.
Sheng, Fugeng, Yiguang Jin, Tong Li, et al.. (2016). Magnetic resonance imaging of osteosarcoma using a bis(alendronate)-based bone-targeted contrast agent. Biomedicine & Pharmacotherapy. 84. 423–429. 7 indexed citations
15.
Hao, Rui, Jing Yu, Zigang Ge, et al.. (2013). Developing Fe3O4 nanoparticles into an efficient multimodality imaging and therapeutic probe. Nanoscale. 5(23). 11954–11954. 44 indexed citations
16.
Kiryu, Shigeru, Yusuke Inoue, Fugeng Sheng, et al.. (2012). Interstitial MR Lymphography in Mice: Comparative Study with Gadofluorine 8, Gadofluorine M, and Gadofluorine P. Magnetic Resonance in Medical Sciences. 11(2). 99–107. 8 indexed citations
17.
Zhou, Cuihong, Jun Zhou, Fugeng Sheng, et al.. (2012). The heme oxygenase-1 inhibitor ZnPPIX induces non-canonical, Beclin 1-independent, autophagy through p38 MAPK pathway. Acta Biochimica et Biophysica Sinica. 44(10). 815–822. 19 indexed citations
18.
Sheng, Fugeng, Yusuke Inoue, Shigeru Kiryu, Makoto Watanabe, & Kuni Ohtomo. (2011). Lymph Drainage from the Mammary Glands in Mice. Academic Radiology. 18(4). 512–517. 3 indexed citations
19.
Sheng, Fugeng, Yusuke Inoue, Shigeru Kiryu, Makoto Watanabe, & Kuni Ohtomo. (2011). Long-term assessment of contrast effects of gadofluorine M and gadofluorine P in magnetic resonance imaging of mice. Japanese Journal of Radiology. 30(1). 86–91. 1 indexed citations
20.
Cheng, Liuquan, Yuangui Gao, Andrea Igoren Guaricci, et al.. (2006). Breath‐hold 3D steady‐state free precession coronary MRA compared with conventional X‐ray coronary angiography. Journal of Magnetic Resonance Imaging. 23(5). 669–673. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feng Ren Breakdown of academic impact, for papers by Rongrong Jin Breakdown of academic impact, for papers by Xiaoyang Liu Breakdown of academic impact, for papers by Jinlan Jiang Breakdown of academic impact, for papers by Andrew Hsu Breakdown of academic impact, for papers by Yelin Wu Breakdown of academic impact, for papers by Xianbing Zhu Breakdown of academic impact, for papers by Yang Du
Rankless by CCL
2026